Pulmonary outcome prediction (POP) tools for cystic fibrosis patients

Pediatric Pulmonology

Volumn 45, Issue 12, 2010, Pages 1156-1166

  Vandevanter, Donald R ^a   Wagener, Jeffrey S ^b   Pasta, David J ^c   Elkin, Eric ^c   Jacobs, Joan R ^d   Morgan, Wayne J ^e   Konstan, Michael W ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c ICON CLINICAL RESEARCH   (United States)

^d GENENTECH INC   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

Author keywords

decline; epidemiology; predictive variables; pulmonary function outcome

Indexed keywords

ADOLESCENT; ALGORITHM; ARTICLE; CHILD; CONSULTATION; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PULMONARY OUTCOME PREDICTION; SPIROMETRY;

ADOLESCENT; AGE FACTORS; ALGORITHMS; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; COUGH; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; RESPIRATORY SOUNDS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SPIROMETRY;

EID: 78649662363     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21311     Document Type: Article

References (41)

1. Chrispin AR, Norman AP,. The systematic evaluation of the chest radiograph in cystic fibrosis. Pediatr Radiol 1974; 2: 101-105.
2. Brasfield D, Hicks G, Soong S-J, Tiller RE,. The chest roentgenogram in cystic fibrosis: a new scoring system. Pediatrics 1979; 63: 24-29.
3. Weatherly MR, Palmer CG, Peters ME, Green CG, Fryback D, Langhough R, Farrell PM,. Wisconsin cystic fibrosis chest radiograph scoring system. Pediatrics 1993; 91: 488-495.
4. Conway SP, Pond MN, Bowler I, Smith DL, Simmonds EJ, Joanes DN, Hambleton G, Hiller EJ, Stableforth DE, Weller P, Littlewood JM,. The chest radiograph in cystic fibrosis: a new scoring system compared with the Chrispin-Norman and Brasfield scores. Thorax 1994; 49: 860-862.
5. Cleveland RH, Neish AS, Zurakowski D, Nichols DP, Wohl ME, Colin AA,. Cystic fibrosis: a system for assessing and predicting progression. AJR Am J Roentgenol 1998; 170: 1067-1072.
6. Shwachman H, Kulczyki LL,. Long term study of one hundred and five patients with cystic fibrosis. Am J Dis Child 1958; 96: 6-15.
7. Taussig LM, Kattwinkel J, Friedewald WT, di Sant'Agnese PA,. A new prognostic score and clinical evaluation system for cystic fibrosis. Pediatrics 1973; 82: 380-390.
8. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry 2007: Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation; 2008.
9. Rosenthal M,. How good are pulmonary function tests as an indicator of short and long term health status? Pediatr Pulmonol 2009; S32: 171-172.
10. Rabin HR, Butler SM, Wohl ME, Geller DE, Colin AA, Schidlow DV, Johnson CA, Konstan MW, Regelmann WE,. Epidemiologic Study of Cystic Fibrosis. Pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol 2004; 37: 400-406.
11. European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP). Guideline on the clinical development of medicinal products for the treatment of cystic fibrosis. EMEA/CHMP/EWP/9147/2008, October, 2009.
12. Konstan MW, Butler SM, Schidlow DV, Morgan WJ, Julius JR, Johnson CA,. Patterns of medical practice in cystic fibrosis: part II. Use of therapies. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Pediatr Pulmonol 1999; 28: 248-254.
13. Johnson C, Butler SM, Konstan MW, Morgan W, Wohl ME,. Factors influencing outcomes in cystic fibrosis: a center-based analysis. Chest 2003; 123: 20-27.
14. Davis PB, Byard PJ, Konstan MW,. Identifying treatments that halt progression of pulmonary disease in cystic fibrosis. Pediatr Res 1997; 41: 161-165.
15. Konstan MW, Morgan WJ, Butler SM, Pasta DJ, Craib ML, Silva SJ, Stokes DC, Wohl ME, Wagener JS, Regelmann WE, Johnson CA, Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr 2007; 151: 134-139.
16. Lum S, Gustafsson P, Ljungberg H, Hülskamp G, Bush A, Carr SB, Castle R, Hoo AF, Price J, Ranganathan S, Stroobant J, Wade A, Wallis C, Wyatt H, Stocks J, London Cystic Fibrosis Collaboration. Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests. Thorax 2007; 62: 341-347.
17. Beydon N, Davis SD, Lombardi E, Allen JL, Arets HG, Aurora P, Bisgaard H, Davis GM, Ducharme FM, Eigen H, Gappa M, Gaultier C, Gustafsson PM, Hall GL, Hantos Z, Healy MJ, Jones MH, Klug B, Lodrup Carlsen KC, McKenzie SA, Marchal F, Mayer OH, Merkus PJ, Morris MG, Oostveen E, Pillow JJ, Seddon PC, Silverman M, Sly PD, Stocks J, Tepper RS, Vilozni D, Wilson NM,. American Thoracic Society/European Respiratory Society Working Group on Infant and Young Children Pulmonary Function Testing. An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med 2007; 175: 1304-1345.
18. Morgan WJ, Butler SM, Johnson CA, Colin AA, FitzSimmons SC, Geller DE, Konstan MW, Light MJ, Rabin HR, Regelmann WE, Schidlow DV, Stokes DC, Wohl ME, Kaplowitz H, Wyatt MM, Stryker S,. Epidemiologic Study of Cystic Fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada. Pediatr Pulmonol 1999; 28: 231-241.
19. Wang X, Dockery DW, Wypij D, Fay ME, Ferris BG,. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 1993; 15: 75-88.
20. Hankinson JL, Odencrantz JR, Fedan KB,. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: 179-187.
21. Konstan MW, Butler SM, Wohl ME, Stoddard M, Matousek R, Wagener JS, Johnson CA, Morgan WJ, Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr 2003; 142: 624-630.
22. Harrell FE, Jr., Regression modeling strategies with applications to linear models, logistic regression, and survival analysis. New York: Springer-Verlag; 2001. pp 247-248.
23. Stanojevic S, Wade A, Stocks J, Hankinson J, Coates AL, Pan H, Rosenthal M, Corey M, Lebecque P, Cole TJ,. Reference ranges for spirometry across all ages: a new approach. Am J Respir Crit Care Med 2008; 177: 253-260.
24. Konstan MW, Wagener JS, VanDevanter DR,. Characterizing aggressiveness and predicting future progression of CF lung disease. J Cyst Fibros 2009; 8: S15-S19.
25. Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, Du Chane J, Carroll PR,. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol 2005; 173: 1938-1942.
26. Miller MK, Lee JH, Blanc PD, Pasta DJ, Gujrathi S, Barron H, Wenzel SE, Weiss ST, TENOR Study Group. TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma. Eur Respir J 2006; 28: 1145-1155.
27. Adamson GD, Pasta DJ,. Endometriosis fertility index: the new, validated endometriosis staging system. Fertil Steril 2009; November 18 [Epub ahead of print].
28. Robinson TE,. High-resolution CT scanning: potential outcome measure. Curr Opin Pulm Med 2004; 10: 537-541.
29. Brody AS, Kosorok MR, Li Z, Broderick LS, Foster JL, Laxova A, Bandla H, Farrell PM,. Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis. J Thorac Imaging 2006; 21: 14-21.
30. Davis SD, Brody AS, Emond MJ, Brumback LC, Rosenfeld M,. Endpoints for clinical trials in young children with cystic fibrosis. Proc Am Thorac Soc 2007; 4: 418-430 [review].
31. Kerem E, Corey M, Kerem BS, Rommens J, Markiewicz D, Levison H, Tsui LC, Durie P,. The relation between genotype and phenotype in cystic fibrosis-analysis of the most common mutation (delta F508). N Engl J Med 1990; 323: 1517-1522.
32. McKone EF, Goss CH, Aitken ML,. CFTR genotype as a predictor of prognosis in cystic fibrosis. Chest 2006; 130: 1441-1447.
33. Schluchter MD, Konstan MW, Drumm ML, Yankaskas JR, Knowles MR,. Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data. Am J Respir Crit Care Med 2006; 174: 780-786.
34. Kraemer R, Blum A, Schibler A, Ammann RA, Gallati S,. Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis. Am J Respir Crit Care Med 2005; 171: 371-378.
35. Gustafsson PM, Aurora P, Lindblad A,. Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis. Eur Respir J 2003; 22: 972-979.
36. Ridker PM, Buring JE, Rifai N, Cook NR,. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. J Am Med Assoc 2007; 297: 611-619.
37. Liou TG, Adler FR, Fitzsimmons SC, Cahill BC, Hibbs JR, Marshall BC,. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001; 153: 345-352.
38. Flume PA, O'Sullivan BP, Robinson KA, Goss CH, Mogayzel PJ, Willey-Courand DB, Bujan J, Finder J, Lester M, Quittell L, Rosenblatt R, Vender RL, Hazle L, Sabadosa K, Marshall B, Cystic Fibrosis Foundation, Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: chronic medication for maintenance of lung health. Am J Respir Crit Care Med 2007; 176: 957-969.
39. 1 decline in children with cystic fibrosis. Am J Respir Crit Care Med 2007; 176: 1084-1089.
40. Ren CL, Pasta DJ, Rasouliyan L, Wagener JS, Konstan MW, Morgan WJ,. The initiation of inhaled corticosteroid therapy in cystic fibrosis patients is associated with a slower rate of lung function decline. J Pediatr 2008; 153: 746-751.
41. VanDevanter DR, Rasouliyan LH, Murphy TM, Morgan WJ, Ren CL, Konstan MW, Wagener JS, for the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Trends in the clinical characteristics of the U.S. cystic fibrosis patient population from 1995 to 2005. Pediatr Pulmonol 2008; 43: 739-744.